Swiss drugmaker Roche Holding AG would not exclude a move into treatments for rare diseases, its CEO said on Wednesday, even if this represented very small numbers of patients. Chief executive Severin ...
View the original article here
This post was made using the
Auto Blogging Software from
WebMagnates.org This line will not appear when posts are made after activating the software to full version.
No comments:
Post a Comment